DE HB24 | 2019-2020 | 150th General Assembly

Status

Spectrum: Slight Partisan Bill (Democrat 9-3)
Status: Introduced on January 4 2019 - 25% progression
Action: 2019-01-23 - Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 3 Favorable, 9 On Its Merits
Text: Latest bill text (Draft #1) [HTML]

Summary

This Act would prohibit insurers and pharmacy benefit managers from engaging in the practice of "clawbacks". When the total cost of a prescription drug to an insurer or pharmacy benefits manager is less than a patient's co-pay, the insurer or pharmacy benefits manager keeps the difference in a practice known as a "clawback".

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

An Act To Amend Title 18 Of The Delaware Code Relating To Copayment Or Coinsurance For Prescription Drugs.

Sponsors


History

DateChamberAction
2019-01-23 Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 3 Favorable, 9 On Its Merits
2019-01-04 Introduced and Assigned to Economic Development/Banking/Insurance/Commerce Committee in House

Delaware State Sources


Bill Comments

feedback